SHERIDAN, WYOMING – November 10, 2024 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced strong third-quarter 2024 results, exceeding its previously issued earnings guidance. The company also provided an update on the ongoing recovery efforts at its North Cove, North Carolina manufacturing facility following the impact of Hurricane Helene.
Financial Performance
SHERIDAN, WYOMING – November 10, 2024 – Baxter International Inc., a global leader in healthcare, has provided an update on the recovery efforts at its North Cove, North Carolina manufacturing site following the impact of Hurricane Helene. The company is focused on supporting its employees, restoring operations, and ensuring ongoing product supply to patients.
Employee and Community Support
SHERIDAN, WYOMING – November 10, 2024 – Two-year-old Nicklaus is a typical toddler by day, full of energy and curiosity. But by night, he transforms into a kidney care superhero, bravely battling a chronic condition he's faced since birth.
Born prematurely with only 5% kidney function, Nicklaus's journey has been filled with challenges. A blockage in his urethra and an enlarged bladder led to a 72-day stay in the neonatal intensive care unit (NICU).
A Devastating Diagnosis and a Family's Strength
SHERIDAN, WYOMING – November 10, 2024 – Baxter, a leading name in the medtech industry, is taking bold steps to transform its supply chain, ensuring that life-saving products reach patients quickly and reliably. In the wake of the COVID-19 pandemic, which exposed vulnerabilities in global supply chains across all sectors, Baxter is investing heavily in innovation to build a more resilient and efficient system.
